These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 27012367)

  • 21. gammadelta T cells in cancer immunotherapy: current status and future prospects.
    Chiplunkar S; Dhar S; Wesch D; Kabelitz D
    Immunotherapy; 2009 Jul; 1(4):663-78. PubMed ID: 20635991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The emerging Protumor role of γδ T lymphocytes: implications for cancer immunotherapy.
    Rei M; Pennington DJ; Silva-Santos B
    Cancer Res; 2015 Mar; 75(5):798-802. PubMed ID: 25660949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pro- and antitumorigenic functions of γδ T cells.
    Fiala GJ; Lücke J; Huber S
    Eur J Immunol; 2024 Aug; 54(8):e2451070. PubMed ID: 38803018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
    Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
    AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetically Induced Tumors in the Oncopig Model Invoke an Antitumor Immune Response Dominated by Cytotoxic CD8β
    Overgaard NH; Principe DR; Schachtschneider KM; Jakobsen JT; Rund LA; Grippo PJ; Schook LB; Jungersen G
    Front Immunol; 2018; 9():1301. PubMed ID: 29930558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
    Wrobel P; Shojaei H; Schittek B; Gieseler F; Wollenberg B; Kalthoff H; Kabelitz D; Wesch D
    Scand J Immunol; 2007; 66(2-3):320-8. PubMed ID: 17635809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of murine gammadelta lymphocyte expansion and effector function by regulatory alphabeta T cells is cell-contact-dependent and sensitive to GITR modulation.
    Gonçalves-Sousa N; Ribot JC; deBarros A; Correia DV; Caramalho I; Silva-Santos B
    Eur J Immunol; 2010 Jan; 40(1):61-70. PubMed ID: 19877017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-activated TCRγδ⁺ T cells from gastric cancer patients induce the antitumor immune response of TCRαβ⁺ T cells via their antigen-presenting cell-like effects.
    Mao C; Mou X; Zhou Y; Yuan G; Xu C; Liu H; Zheng T; Tong J; Wang S; Chen D
    J Immunol Res; 2014; 2014():593562. PubMed ID: 24741609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promising cell-based immunotherapy using gamma delta T cells: together is better.
    Déchanet-Merville J
    Clin Cancer Res; 2014 Nov; 20(22):5573-5. PubMed ID: 25278452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.
    Stolk D; van der Vliet HJ; de Gruijl TD; van Kooyk Y; Exley MA
    Front Immunol; 2018; 9():1990. PubMed ID: 30298063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells.
    Niu C; Jin H; Li M; Xu J; Xu D; Hu J; He H; Li W; Cui J
    BMC Immunol; 2015 Oct; 16():61. PubMed ID: 26458364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Ambiguous Role of γδ T Lymphocytes in Antitumor Immunity.
    Chitadze G; Oberg HH; Wesch D; Kabelitz D
    Trends Immunol; 2017 Sep; 38(9):668-678. PubMed ID: 28709825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside.
    Braza MS; Klein B
    Br J Haematol; 2013 Jan; 160(2):123-32. PubMed ID: 23061882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gamma Delta (γδ) T Cells and Their Involvement in Behçet's Disease.
    Hasan MS; Bergmeier LA; Petrushkin H; Fortune F
    J Immunol Res; 2015; 2015():705831. PubMed ID: 26539557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. γδ T Cells in Tumor Microenvironment.
    Imbert C; Olive D
    Adv Exp Med Biol; 2020; 1273():91-104. PubMed ID: 33119877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain.
    Izumi T; Kondo M; Takahashi T; Fujieda N; Kondo A; Tamura N; Murakawa T; Nakajima J; Matsushita H; Kakimi K
    Cytotherapy; 2013 Apr; 15(4):481-91. PubMed ID: 23391461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid alphabeta TCR-mediated responses in gammadelta T cells transduced with cancer-specific TCR genes.
    Hiasa A; Nishikawa H; Hirayama M; Kitano S; Okamoto S; Chono H; Yu SS; Mineno J; Tanaka Y; Minato N; Kato I; Shiku H
    Gene Ther; 2009 May; 16(5):620-8. PubMed ID: 19242528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymic Determinants of γδ T Cell Differentiation.
    Muñoz-Ruiz M; Sumaria N; Pennington DJ; Silva-Santos B
    Trends Immunol; 2017 May; 38(5):336-344. PubMed ID: 28285814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-181a/b-1 Is Not Required for Innate γδ NKT Effector Cell Development.
    Sandrock I; Ziętara N; Łyszkiewicz M; Oberdörfer L; Witzlau K; Krueger A; Prinz I
    PLoS One; 2015; 10(12):e0145010. PubMed ID: 26673421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. gammadelta T cells: a new frontier for immunotherapy?
    Lamb LS; Lopez RD
    Biol Blood Marrow Transplant; 2005 Mar; 11(3):161-8. PubMed ID: 15744234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.